Back to ACRS
CITADEL ADVISORS LLC ACRS Position History
Aclaris Therapeutics, Inc. • Healthcare
Quarters held
12
Latest value
$550K
Q2 2026
Peak value
$8.3M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $1.6M |
| Q1 2026 | $1.7M |
| Q1 2026 | $6.8M |
| Q1 2026 | $384K |
| Q2 2026 | $997K |
| Q2 2026 | $2.8M |
| Q2 2026 | $8.3M |
| Q2 2026 | $550K |
| Q2 2026 | $997K |
| Q2 2026 | $2.8M |
| Q2 2026 | $8.3M |
| Q2 2026 | $550K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $550K | 104.0K | — | — |
| Q2 2026 | $8.3M | 1.57M | — | — |
| Q2 2026 | $2.8M | 521.0K | — | — |
| Q2 2026 | $997K | 188.5K | — | — |
| Q2 2026 | $550K | 104.0K | — | — |
| Q2 2026 | $8.3M | 1.57M | — | — |
| Q2 2026 | $2.8M | 521.0K | — | — |
| Q2 2026 | $997K | 188.5K | — | — |
| Q1 2026 | $384K | 102.3K | — | — |
| Q1 2026 | $6.8M | 1.82M | — | — |
| Q1 2026 | $1.7M | 466.4K | — | — |
| Q1 2026 | $1.6M | 425.1K | — | — |
Other funds holding ACRS
$23.2M
$20.9M